期刊文献+

心脏植入型电子器械患者的围手术期管理 被引量:1

Perioperative management of patients with cardiac implantable electronic devices
原文传递
导出
摘要 背景 心脏植入型电子器械(cardiac implantable electronic devices,CIEDs)包括起搏器、植入型心律转复除颤器(implantable cardioverter defibrillators,ICDs)和心脏再同步治疗(cardiac resynchronization therapy,CRT)装置.目前中国每年安装ICDs 2 000多台、CRT装置约为2 200台,每年每百万人口安装心脏起搏器38台. 目的 帮助麻醉医师掌握CIEDs患者的围手术期管理技术. 内容 回顾CIEDs患者的围手术期管理. 趋向 CIEDs患者可能需要接受外科手术或胃肠镜等微创手术.围手术期CIEDs患者管理情况比较复杂,迄今为止也很少有关于围手术期CIEDs管理的指南. Background Cardiac implantable electronic devices (CIEDs) include pacemakers,implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT).At present,the number of installed ICDs in China annually is more than 2 000 and the CRT device is about 2 200.There are 38 per million people receiving heart pacemakers.Objective The anesthesiologist should know the perioperative management of patients with cardiac implantable electronic devices.Content In this article,we reviewed the perioperative management of patients with CIEDs.We hope to help the anesthesiologists.Trend Such patients with CIEDs may also need to accept the surgical operation or gastrointestinal endoscopy or other minimally invasive surgery.The management of patients with electronic devices in perioperative period is very complicated.Continuing education has not kept pace with.So far,there are few guidelines on the management of CIEDs.
出处 《国际麻醉学与复苏杂志》 CAS 2016年第9期831-834,838,共5页 International Journal of Anesthesiology and Resuscitation
关键词 心脏植入型电子器械 起搏器 植入型心律转复除颤器 心脏再同步治疗装置 围手术期管理 Cardiac implantable electronic devices Pacemaker Implantable cardioverter defibrillator Cardiac resynchronization therapy Perioperative management
  • 相关文献

参考文献1

二级参考文献19

  • 1华伟,张澍,王方正,唐闽,陈柯萍,牛红霞,陈若涵,陈新.植入型心律转复除颤器抗心动过速起搏治疗室性心动过速疗效评价[J].中华心律失常学杂志,2005,9(5):341-343. 被引量:13
  • 2浦介麟,王洪涛,刘同库,马克娟,李宁,姚焰,楚建民,方丕华,马坚,华伟,张澍,王方正.31例致心律失常性右室心肌病的临床研究[J].中华心血管病杂志,2007,35(1):24-27. 被引量:14
  • 3Heidenreich PA, Keeffe B, McDonald KM, et al. Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death. Am Heart J,2002,144:422-430.
  • 4Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg(CASH). Circulation ,2000,102:748-754.
  • 5Klein RC, Raitt MH, Wilkoff BL, et al. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators ( AVID ) Trial. J Cardiovasc Electrophysiol, 2003,14:940-948.
  • 6Proclemer A, Ghidina M, Facchin D, et al. Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: data from Italian ICD Registry for the years 2001-6. Pacing Clin Electrophysiol, 2009,32:434-445.
  • 7Watkins H ,Ashrafian H, Redwood C, et al. Inherited cardiomyopathies. N Engl J Med,2011,364 : 1643-1656.
  • 8Roguin A,Bomma CS, Nasir K, et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coil Cardiol,2004,43:1843-1852.
  • 9Bhonsale A, James CA,Tichnell C, et al. Incidence and predictors of implantable cardioverter-defibriliator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coil Cardiol,2011,58 :1485-1496.
  • 10Delise P, Allocca G, Marras E, et al. Risk stratification in Brugada syndrome. G Ital Cardiol,2011,12 :400-407.

共引文献2

同被引文献3

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部